Phase II Trial of Preoperative Pemetrexed and Carboplatin in Patients With Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Carboplatin (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 03 Mar 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Dec 2014 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016 according to ClinicalTrials.gov record.
- 01 Jan 2014 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov